Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

American Parkinson Disease Association Scientific Advisory Board Evaluates Exciting Research Ideas for 2018-2019 Research Funding
  • USA - English


News provided by

American Parkinson Disease Association

May 25, 2018, 05:00 ET

Share this article

Share toX

Share this article

Share toX

APDA SAB members work diligently to determine which grants will be recommended for funding.
APDA SAB members work diligently to determine which grants will be recommended for funding.

NEW YORK (PRWEB) May 25, 2018 -- The American Parkinson Disease Association’s(APDA) Scientific Advisory Board recently met to review 70 grant submissions all vying for funding to be awarded in the field of Parkinson’s research. In addition, the Scientific Advisory Board (SAB) reviewed proposals for new APDA Centers of Advanced Research, to be located at academic medical centers across the United States that have proven themselves as leaders in Parkinson’s disease (PD) research. Final funding decisions will be announced in August.

The only way to push the field of Parkinson’s disease research forward is to invest research funds to support new and promising ideas, as well as investigators with a long-term commitment to PD. -- Dr. David G. Standaert, Chairman of the APDA SAB

Post this

APDA’s mission is to provide the support, education, and research to help everyone impacted by PD live life to the fullest and as such, focuses on advancing scientific research that will be impactful and support this mission. “The only way to push the field of Parkinson’s disease research forward is to invest research funds to support new and promising ideas, as well as investigators with a long-term commitment to PD,” commented Dr. David G. Standaert, Chairman of the SAB.

APDA's SAB is comprised of scientists with a wide array of backgrounds and expertise in all areas relevant to PD. “It’s exciting for APDA leadership to watch the SAB debate the merits and weaknesses of the grant requests in an intellectually rigorous and honest manner,” said Dr. Rebecca Gilbert, VP, Chief Scientific Officer at APDA. “It’s clear from our grant submissions that there is no shortage of research ideas which may lead to increased understanding of and eventually a cure for PD. Grants investigating everything from the basic biochemistry of dopamine neurons to potential disease biomarkers were discussed.”

Also in attendance was Patrick McDermott, Chairman of APDA’s National Board of Directors who remarked, “We ask a lot of our SAB members. They put a tremendous amount of time, effort and dedication into these meetings, including analytical review of research proposals both prior to and during each meeting. Their contribution and expertise is integral in fulfilling our organization’s research mission. It was exciting to see some really innovative ideas within the grant requests. The SAB had their work cut out for them at this meeting – there were lots of smart projects that deserve to be funded and some tough decisions to make.”

APDA grants fall into several categories. Post-Doctoral Fellowships are awarded at $35,000 per year, while Research grants are awarded at $50,000 per year. Additionally, the prestigious George C. Cotzias Fellowship is a $240,000 grant given over three years to support promising young physician-scientists who are rising stars working to establish their careers in PD research, teaching, and patient service. APDA Centers for Advanced Research receive $100,000 per year to support PD research activities.

In addition to the members of the SAB whom have been committed to APDA for numerous years, two new members joined the SAB this year: Jill Ostrem, MD, Professor of Neurology at University of California, San Francisco, and Vivek K. Unni, MD, PhD, Assistant Professor of Neurology, Oregon Health and Science University, and the 2016-2018 recipient of the George C. Cotzias Fellowship.

Each SAB meeting is also an important opportunity for updates on previously-funded research. In addition to the discussion of new research grants, Dr. J. Timothy Greenamyre, Director of the APDA Center for Advanced Research at the University of Pittsburgh, updated the SAB on the APDA-funded research being conducted at his institution. He focused on a gene therapy trial which is currently underway, in which the gene for Aromatic amino acid decarboxylase (AADC), embedded within an engineered virus, is introduced into the basal ganglia part of the brain in order to increase the efficiency of conversion of levodopa to dopamine. He also discussed leucine-rich repeat kinase 2 (LRRK2), a known genetic contributor to the development of PD, and presented data that this molecule plays a role in PD even in people who do not have a LRRK2 mutation.

This critical research funding is only possible due to the financial support from APDA’s steadfast supporters and the dedicated work of the SAB who gather on a regular basis to review and recommend funding the most cutting-edge projects.

CONTACT: Stephanie Paul | 718-981-8062 | spaul(at)apdaparkinson.org | http://www.apdaparkinson.org                

About the American Parkinson Disease Association:
The American Parkinson Disease Association (APDA) is the largest grassroots network dedicated to fighting Parkinson’s disease (PD) and works tirelessly to assist the more than 1 million Americans with PD live life to the fullest in the face of this chronic, neurological disorder. Founded in 1961, APDA has raised and invested more than $170 million to provide outstanding patient services and educational programs, elevate public awareness about the disease, and support research designed to unlock the mysteries of PD and ultimately put an end to this disease.

SAB GROUP PHOTO:
(Back row L-R) Joel S. Perlmutter, MD, Washington University School of Medicine; Dennis W. Dickson, MD, Mayo Clinic, Jacksonville; Un Jung Kang, MD, Columbia University College of Physicians and Surgeons; Richard Myers, PhD, Boston University School of Medicine; David G. Standaert, MD, PhD, Chairman of the APDA SAB, University of Alabama at Birmingham; Patrick McDermott, Chairman, APDA Board of Directors; Clemens R. Scherzer, MD, Harvard Medical School and Brigham & Women's Hospital; Vivek K. Unni, MD, PhD, Oregon Health & Science University.
(Front row L-R); Mary Maral Mouradian, MD, Rutgers Robert Wood Johnson Medical School: Marie Hélène Saint-Hilaire, MD, FRCP (C), Boston University School of Medicine; Leslie A. Chambers, President & CEO, APDA; Rebecca Gilbert, MD, PhD, VP and Chief Scientific Officer, APDA; J. Timothy Greenamyre, MD, PhD, University of Pittsburgh Medical Center.
(Not pictured); Mahlon R. DeLong, MD, Emory University School of Medicine; Laura Marsh, MD, Michael E. DeBakey VA Medical Center; Jill L. Ostrem, MD, University of California San Francisco; Evan Yale Snyder, MD, PhD, The Burnham Institute.

Stephanie Paul, American Parkinson Disease Association, http://www.apdaparkinson.org, +1 718-981-8062, [email protected]

Modal title

APDA Scientific Advisory Board Members at May 2018 Meeting (consult press release for full listing of names)
APDA Scientific Advisory Board Members at May 2018 Meeting (consult press release for full listing of names)
APDA SAB Meeting press release
View PDF
APDA SAB Meeting press release
APDA Scientific Advisory Board Members at May 2018 Meeting (consult press release for full listing of names) APDA SAB Meeting press release

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.